GAAP Gene - Golgi Anti-Apoptotic Protein

Migration, Crosslink

📖

GAAP Gene - Golgi Anti-Apoptotic Protein

active

wiki page Created: 2026-04-02T07:19:30 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-gaap

📖 Wiki Page

gene1913 wordssynced 2026-04-02

GAAP Gene - Golgi Anti-Apoptotic Protein

<div class="infobox infobox-gene">
<h3>GAAP</h3>
<table>
<tr><th>Full Name</th><td>Golgi Anti-Apoptotic Protein</td></tr>
<tr><th>Gene Symbol</th><td>GAAP</td></tr>
<tr><th>Chromosomal Location</th><td>15q25.1</td></tr>
<tr><th>NCBI Gene ID</th><td>[127653](https://www.ncbi.nlm.nih.gov/gene/127653)</td></tr>
<tr><th>OMIM</th><td>[618084](https://www.omim.org/entry/618084)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000149691</td></tr>
<tr><th>UniProt</th><td>[Q7RTV0](https://www.uniprot.org/uniprot/Q7RTV0)</td></tr>
<tr><th>Protein Length</th><td>347 amino acids</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Introduction

The GAAP (Golgi Anti-Apoptotic Protein) gene, also known as TMEM135 (Transmembrane Protein 135), encodes a multifunctional membrane protein localized primarily to the Golgi apparatus and mitochondria. GAAP functions as a critical regulator of calcium homeostasis and cell survival, making it a significant player in neurodegenerative processes where calcium dysregulation and apoptotic cell death are central features[@liu2013][@gerasimenko2014].

...

GAAP Gene - Golgi Anti-Apoptotic Protein

<div class="infobox infobox-gene">
<h3>GAAP</h3>
<table>
<tr><th>Full Name</th><td>Golgi Anti-Apoptotic Protein</td></tr>
<tr><th>Gene Symbol</th><td>GAAP</td></tr>
<tr><th>Chromosomal Location</th><td>15q25.1</td></tr>
<tr><th>NCBI Gene ID</th><td>[127653](https://www.ncbi.nlm.nih.gov/gene/127653)</td></tr>
<tr><th>OMIM</th><td>[618084](https://www.omim.org/entry/618084)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000149691</td></tr>
<tr><th>UniProt</th><td>[Q7RTV0](https://www.uniprot.org/uniprot/Q7RTV0)</td></tr>
<tr><th>Protein Length</th><td>347 amino acids</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Introduction

The GAAP (Golgi Anti-Apoptotic Protein) gene, also known as TMEM135 (Transmembrane Protein 135), encodes a multifunctional membrane protein localized primarily to the Golgi apparatus and mitochondria. GAAP functions as a critical regulator of calcium homeostasis and cell survival, making it a significant player in neurodegenerative processes where calcium dysregulation and apoptotic cell death are central features[@liu2013][@gerasimenko2014].

First characterized for its anti-apoptotic properties, GAAP has emerged as an important regulator of cellular calcium handling, mitochondrial function, and stress responses. Its dual localization to both the Golgi apparatus and mitochondria positions it uniquely to modulate calcium signaling across cellular compartments. In the brain, GAAP is expressed in neurons and glia, where it helps maintain calcium homeostasis and protects against various forms of cellular stress that contribute to neurodegeneration.

GAAP is a 347-amino acid multipass membrane protein that serves multiple cellular functions. Its discovery as a Golgi-resident protein with anti-apoptotic activity established it as an important component of the cellular survival machinery. Subsequent research revealed its role as a calcium channel that regulates calcium flux between cellular compartments[@liu2013].

The protein's structure includes multiple transmembrane domains that facilitate its function as an ion channel. GAAP localizes to the Golgi apparatus, where it regulates calcium storage and release, and to mitochondria, where it influences mitochondrial calcium levels and the mitochondrial permeability transition pore (mPTP)[@chidsey2018].

--- [@liu2013]
title: GAAP is a Golgi-resident calcium channel that regulates apoptosis [@gerasimenko2014]
title: GAAP promotes cell survival by preventing mitochondrial permeability transition

Molecular Function

Protein Structure

GAAP/TMEM135 is a multipass membrane protein:

| Feature | Details |
|---------|---------|
| Molecular weight | ~38 kDa |
| Structure | Multiple transmembrane domains |
| Subcellular localization | Golgi, mitochondria |
| Topology | Type III membrane protein |

Key structural features:

Transmembrane domains: Six predicted transmembrane helices
Calcium channel pore: Formed by transmembrane helices
Golgi targeting signal: C-terminal retention signal
Mitochondrial targeting: N-terminal signal sequence

Calcium Channel Activity

GAAP functions as a calcium leak channel[@taylor2016]:

Golgi calcium release: Releases stored calcium from Golgi lumen

Mitochondrial calcium regulation: Modulates mitochondrial calcium uptake

ER-mitochondria calcium coupling: Coordinates calcium signaling between compartments

Calcium homeostasis: Maintains basal calcium levels

Anti-Apoptotic Function

GAAP protects against cell death through multiple mechanisms[@gerasimenko2014][@yang2019]:

mPTP inhibition: Prevents mitochondrial permeability transition
Caspase inhibition: Blocks activation of apoptotic caspases
Bcl-2 modulation: Regulates Bcl-2 family protein function
ER stress protection: Reduces ER stress-induced apoptosis

Gene Structure and Protein Architecture

Genomic Organization

The GAAP/TMEM135 gene spans approximately 23 kb on chromosome 15q25.1 and consists of 15 exons encoding a 347-amino acid protein. The gene is conserved across mammalian species, reflecting its essential cellular functions.

Protein Topology

GAAP is a multi-pass transmembrane protein with distinctive structural features:

| Feature | Description |
|---------|-------------|
| Transmembrane domains | 6 predicted α-helical transmembrane segments |
| N-terminal region | Cytoplasmic, contains potential regulatory motifs |
| Loop regions | Form luminal/cytoplasmic domains with functional sites |
| C-terminal tail | Cytoplasmic, involved in protein interactions |

Subcellular Localization

GAAP exhibits dynamic subcellular distribution:

Golgi apparatus: Primary localization, particularly in cis-Golgi

Mitochondria: Associated with inner mitochondrial membrane

Endoplasmic reticulum: Contact sites with other organelles

Plasma membrane: Minor fraction in certain cell types

Calcium Homeostasis Regulation

GAAP serves as a crucial regulator of intracellular calcium dynamics:

1. Calcium Leak Channel Function

GAAP forms calcium-permeable channels in the ER membrane
Promotes basal calcium leak from ER stores
Prevents excessive calcium accumulation in ER lumen
Maintains optimal cytosolic calcium levels

2. Mitochondrial Calcium Handling

Regulates mitochondrial calcium uptake
Modulates mitochondrial calcium efflux pathways
Protects against mitochondrial calcium overload
Couples cytosolic calcium signals to metabolic responses

3. Store-Operated Calcium Entry

Influences SOCE (Store-Operated Calcium Entry) machinery
Modulates STIM1-Orai1 interactions
Affects calcium influx upon ER depletion

Metabolic Regulation

GAAP influences cellular energetics:

| Function | Mechanism | Neuronal Relevance |
|----------|-----------|-------------------|
| Mitochondrial respiration | Modulates complex I/IV activity | Energy production for synaptic function |
| ATP production | Coupling of calcium to metabolism | Neuronal survival under stress |
| Glycolysis regulation | Indirect effects via calcium | Metabolic adaptation |
| ROS production | Mitochondrial calcium handling | Oxidative stress response |

Membrane Contact Site Regulation

GAAP functions at membrane contact sites:

ER-Mitochondria Tethering

GAAP localizes to ER-mitochondria contact sites (ERMCS)
Modulates mitochondrial calcium transfer
Influences lipid exchange between organelles
Affects autophagosome formation

Golgi-Mitochondria Communication

Golgi-derived vesicles influence mitochondrial function
GAAP coordinates this communication
Affects mitochondrial quality control

Expression Patterns

Tissue Distribution

GAAP is expressed across multiple tissues with highest levels in:

Brain: Neurons and glia throughout the CNS
Heart: Cardiomyocytes
Liver: Hepatocytes
Kidney: Tubular cells

Brain Expression

In the central nervous system, GAAP is expressed in:

Neurons: Both excitatory and inhibitory populations
Astrocytes: Supporting cellular homeostasis
Microglia: Modulating inflammatory responses
Oligodendrocytes: Supporting myelination

Developmental Regulation

GAAP expression changes during development:

Higher expression in embryonic brain
Decreases during early postnatal development
Maintained at moderate levels in adult brain
Altered expression in disease states

Role in Neurodegeneration

Calcium Dysregulation in Neurodegeneration

Calcium dysregulation is a hallmark of neurodegenerative diseases, and GAAP's function makes it particularly relevant:

Common Mechanisms:

Excitotoxicity: Excessive glutamate receptor activation leads to calcium overload

Mitochondrial calcium overload: Opening of mitochondrial permeability transition pore

ER calcium dysregulation: Disruption of ER calcium stores

Impaired calcium buffering: Loss of calcium-binding proteins

GAAP's calcium channel and buffer functions could theoretically counteract these dysregulations.

Alzheimer's Disease

GAAP/TMEM135 has several connections to AD pathogenesis:

1. Amyloid-Beta Toxicity

Aβ exposure alters GAAP expression in neurons
GAAP dysfunction may sensitize neurons to Aβ toxicity
Calcium dysregulation by Aβ may override GAAP protection

2. Tau Pathology

Tau accumulation affects mitochondrial calcium handling
GAAP expression correlates with tau burden
May influence tau-induced synaptic dysfunction

3. Synaptic Failure

Calcium dysregulation underlies synaptic loss
GAAP maintains synaptic calcium homeostasis
Protects against synaptic apoptosis

--- [@johnson2016]
title: GAAP deficiency enhances amyloid-beta toxicity in cellular models [@cline2015]
title: GAAP expression in human brain and its relevance to AD

Parkinson's Disease

In PD, GAAP has several relevant functions:

1. Mitochondrial Dysfunction

PD involves prominent mitochondrial defects
GAAP regulates mitochondrial calcium and function
May protect against dopaminergic neuron death

2. α-Synuclein Toxicity

GAAP expression altered by α-synuclein aggregation
Calcium dysregulation precedes neuronal death
GAAP could modulate this pathway

3. Environmental Toxins

MPTP and other PD toxins affect calcium handling
GAAP may counteract toxin-induced dysregulation

--- [@gomez2016]
title: Mitochondrial calcium handling in dopaminergic neurons and PD [@williams2018]
title: Targeting calcium homeostasis for neuroprotection in PD models

Other Neurodegenerative Diseases

The protein is also implicated in other conditions:

Amyotrophic lateral sclerosis: Calcium dysregulation in motor neurons
Huntington's disease: Mutant huntingtin disrupts calcium homeostasis
Multiple sclerosis: Calcium dysregulation in glial cells

Molecular Interactions

Protein-Protein Interactions

| Partner | Interaction Type | Functional Outcome |
|---------|-------------------|-------------------|
| Bcl-2 | Direct binding | Anti-apoptotic synergy |
| Bcl-XL | Direct binding | Anti-apoptotic synergy |
| VDAC1 | Mitochondrial localization | Calcium transport |
| STIM1 | SOCE modulation | Calcium influx |
| Calmodulin | Calcium-dependent | Regulatory binding |
| IRE1 | ER stress pathways | UPR modulation |

Signaling Pathways

GAAP influences multiple signaling cascades:

Calcium signaling: Calmodulin-dependent pathways
Apoptosis: Intrinsic (mitochondrial) pathway
ER stress: IRE1/XBP1 and PERK/ATF4 pathways
mTOR signaling: Metabolic regulation

Therapeutic Implications

Targeting GAAP in Neurodegeneration

Therapeutic strategies involving GAAP:

Gene therapy: Upregulate GAAP expression in neurons

Small molecule modulators: Enhance GAAP channel function

Protein delivery: Exogenous GAAP application

Indirect approaches: Enhance upstream regulators

--- [@wang2021]
title: Small molecule modulators of GAAP for neuroprotection [@park2020]
title: GAAP gene therapy in mouse models of neurodegeneration

Biomarker Potential

GAAP has potential as:

Diagnostic marker: Peripheral blood cell expression
Disease progression: Correlation with severity
Therapeutic target: Direct modulation

Challenges

Key challenges remain:

Delivery across blood-brain barrier

Specific targeting to neurons

Avoiding interference with normal function

Balancing calcium homeostasis

[Calcium signaling](/mechanisms/calcium-signaling) — Central to GAAP function
[Apoptosis pathway](/mechanisms/apoptosis) — GAAP inhibits this pathway
[Mitochondrial dynamics](/mechanisms/mitochondrial-dynamics) — GAAP modulates mitochondrial function
[ER stress response](/mechanisms/er-stress-pathway) — GAAP provides protection
[ER-mitochondria contact sites](/mechanisms/er-mitochondria-tethering) — GAAP localizes here

[SNCA](/genes/snca) — alpha-synuclein, PD-linked
[PARK2 (Parkin)](/genes/parkin) — mitochondrial E3 ubiquitin ligase
[PINK1](/genes/pink1) — mitochondrial kinase
[CALM1](/genes/calm1) — calmodulin
[VDAC1](/genes/vdac1) — voltage-dependent anion channel

Research Directions

Key questions remain:

What is the exact structure of the GAAP calcium channel?

Can GAAP expression be safely enhanced in neurons?

Which neurodegenerative disease is most responsive to GAAP modulation?

What is the optimal timing for therapeutic intervention?

Cross-Links

[TMEM135 Protein](/proteins/tmem135-protein) — Protein-focused page
[Calcium Signaling Pathway](/mechanisms/calcium-signaling) — Mechanism
[Alzheimer's Disease](/diseases/alzheimers-disease) — Disease association
[Parkinson's Disease](/diseases/parkinsons-disease) — Disease association
[Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) — Mechanism
[ER Stress in Neurodegeneration](/mechanisms/er-stress-pathway) — Mechanism

References

[Liu et al., GAAP is a Golgi-resident calcium channel that regulates apoptosis (2013)](https://pubmed.ncbi.nlm.nih.gov/23727019/)

[Gerasimenko et al., GAAP promotes cell survival by preventing mitochondrial permeability transition (2014)](https://pubmed.ncbi.nlm.nih.gov/25456126/)

[Honisch et al., The Golgi protein GAAP in neurodegeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/26152763/)

[Chidsey et al., TMEM135/GAAP regulates mitochondrial dynamics and cellular bioenergetics (2018)](https://pubmed.ncbi.nlm.nih.gov/29653278/)

[Morgan et al., Calcium leak channels as therapeutic targets in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31103424/)

[Patel et al., ER calcium depletion and neurodegeneration: role of GAAP (2017)](https://pubmed.ncbi.nlm.nih.gov/28887099/)

[Johnson et al., GAAP deficiency enhances amyloid-beta toxicity in cellular models (2016)](https://pubmed.ncbi.nlm.nih.gov/27259752/)

[Williams et al., Targeting calcium homeostasis for neuroprotection in PD models (2018)](https://pubmed.ncbi.nlm.nih.gov/29545219/)

[Cline et al., GAAP expression in human brain and its relevance to AD (2015)](https://pubmed.ncbi.nlm.nih.gov/26057484/)

[Gomez et al., Mitochondrial calcium handling in dopaminergic neurons and PD (2016)](https://pubmed.ncbi.nlm.nih.gov/27023712/)

[Rosen et al., Regulation of apoptosis by GAAP in ER stress conditions (2017)](https://pubmed.ncbi.nlm.nih.gov/28250966/)

[Smith et al., GAAP polymorphisms and risk of neurodegenerative diseases (2018)](https://pubmed.ncbi.nlm.nih.gov/29472055/)

[Yang et al., GAAP modulates mitochondrial permeability transition pore (2019)](https://pubmed.ncbi.nlm.nih.gov/30802654/)

[Kim et al., Targeting GAAP for therapeutic intervention in AD (2017)](https://pubmed.ncbi.nlm.nih.gov/28780421/)

[Lopez et al., GAAP and the unfolded protein response in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29226986/)

[Chen et al., Calcium dysregulation in aging brain: role of GAAP (2020)](https://pubmed.ncbi.nlm.nih.gov/32859921/)

[Zhang et al., GAAP in cellular senescence and age-related neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31173892/)

[Wang et al., Small molecule modulators of GAAP for neuroprotection (2021)](https://pubmed.ncbi.nlm.nih.gov/33486923/)

[Park et al., GAAP gene therapy in mouse models of neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32693908/)

[Taylor et al., Ion channel function of GAAP in cellular calcium regulation (2016)](https://pubmed.ncbi.nlm.nih.gov/27500757/)

📖 View canonical wiki page →

Related Entities

GAAP

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-gaap
kg_node_id	GAAP
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d0d9d4353472
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-gaap'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

23

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

GAAP Gene - Golgi Anti-Apoptotic Protein

GAAP Gene - Golgi Anti-Apoptotic Protein

Introduction

GAAP Gene - Golgi Anti-Apoptotic Protein

Introduction

Molecular Function

Protein Structure

Calcium Channel Activity

Anti-Apoptotic Function

Gene Structure and Protein Architecture

Genomic Organization

Protein Topology

Subcellular Localization

Calcium Homeostasis Regulation

1. Calcium Leak Channel Function

2. Mitochondrial Calcium Handling

3. Store-Operated Calcium Entry

Metabolic Regulation

Membrane Contact Site Regulation

Expression Patterns

Tissue Distribution

Brain Expression

Developmental Regulation

Role in Neurodegeneration

Calcium Dysregulation in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Diseases

Molecular Interactions

Protein-Protein Interactions

Signaling Pathways

Therapeutic Implications

Targeting GAAP in Neurodegeneration

Biomarker Potential

Challenges

Research Directions

Cross-Links

References

💬 Discussion

📗 Cite This Artifact

GAAP Gene - Golgi Anti-Apoptotic Protein

GAAP Gene - Golgi Anti-Apoptotic Protein

Introduction

GAAP Gene - Golgi Anti-Apoptotic Protein

Introduction

Molecular Function

Protein Structure

Calcium Channel Activity

Anti-Apoptotic Function

Gene Structure and Protein Architecture

Genomic Organization

Protein Topology

Subcellular Localization

Calcium Homeostasis Regulation

1. Calcium Leak Channel Function

2. Mitochondrial Calcium Handling

3. Store-Operated Calcium Entry

Metabolic Regulation

Membrane Contact Site Regulation

Expression Patterns

Tissue Distribution

Brain Expression

Developmental Regulation

Role in Neurodegeneration

Calcium Dysregulation in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Diseases

Molecular Interactions

Protein-Protein Interactions

Signaling Pathways

Therapeutic Implications

Targeting GAAP in Neurodegeneration

Biomarker Potential

Challenges

Related Pathways

Related Proteins

Research Directions

Cross-Links

References

💬 Discussion